candesartan cilexetil has been researched along with perindopril in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Paull, JR; Widdop, RE | 1 |
Amemiya, M; Ando, Y; Asano, Y; Honma, S; Iimura, O; Kusano, E; Muto, S; Tanba, K; Yanagiba, S | 1 |
Clark, AL; Cleland, JG; Coletta, AP; Freemantle, N; Loh, H; Memon, A | 1 |
Akioka, K; Enomoto, S; Iwao, H; Izumi, Y; Kusuyama, T; Matsumoto, R; Nishiya, D; Omura, T; Takeuchi, K; Yoshikawa, J; Yoshiyama, M | 1 |
Buda, V; Cristescu, C; Suciu, L; Tomescu, MC; Topîrceanu, A; Udrescu, L; Udrescu, M | 1 |
7 other study(ies) available for candesartan cilexetil and perindopril
Article | Year |
---|---|
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Vessels; Cardiomegaly; Cardiovascular System; Drug Administration Schedule; Heart Rate; Hydralazine; Hypertension; Kidney; Male; Motor Activity; Perindopril; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Vasodilator Agents | 2001 |
[Additive antiproteinuric effect of angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis].
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Chronic Disease; Collagen Type IV; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Male; Perindopril; Proteinuria; Tetrazoles; Treatment Outcome | 2003 |
Clinical trials update from the European Society of Cardiology: CHARM, BASEL, EUROPA and ESTEEM.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Azetidines; Benzimidazoles; Benzylamines; Biphenyl Compounds; Coronary Disease; Europe; Heart Failure; Humans; Natriuretic Peptide, Brain; Perindopril; Prodrugs; Randomized Controlled Trials as Topic; Tetrazoles | 2003 |
Angiotensin blockade inhibits osteopontin expression in non-infarcted myocardium after myocardial infarction.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Chemokine CCL2; Echocardiography, Doppler; Male; Myocardial Infarction; Myocardium; Organ Size; Osteopontin; Perindopril; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar; RNA, Messenger; Sialoglycoproteins; Tetrazoles; Ventricular Remodeling | 2005 |
Evaluation of patients diagnosed with essential arterial hypertension through network analysis.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Essential Hypertension; Female; Humans; Hypertension; Male; Middle Aged; Nebivolol; Perindopril; Prospective Studies; Tetrazoles | 2016 |